Literature DB >> 6319884

Loperamide: evidence of interaction with mu and delta opioid receptors.

G Giagnoni, L Casiraghi, R Senini, L Revel, D Parolaro, M Sala, E Gori.   

Abstract

Loperamide was tested on electrically-evoked contractions using a series of "in vitro" isolated preparations, in comparison with morphine, met-enkephalin, beta-endorphin, ethylketocyclazocine used as representative agonists of mu, delta, epsilon, kappa receptors respectively. The IC50 of loperamide on myenteric plexus longitudinal muscle of guinea pig ileum was found to be 1.90 X 10(-7)M and equal to that of morphine. The IC50 on mouse vas deferens was found to be 13.02 X 10(-7)M. In this tissue, loperamide resulted as active as morphine, but 54 times less active than met-enkephalin (IC50 0.24 X 10(-7)M). On the rat vas deferens where, as expected, beta-endorphin was strongly active (IC50 1.38 X 10(-7)M), morphine exerted a stimulatory action within the range 10(-5)M-10(-4)M and loperamide was only poorly depressive. The Ke value of naloxone, a specific mu receptor antagonist, against loperamide in the guinea pig ileum was 3.83 nM, and in the mouse vas deferens was 82.87 nM indicating that loperamide in the guinea pig ileum acts on mu receptors while in the mouse vas deferens on another opiate receptor.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6319884     DOI: 10.1016/0024-3205(83)90506-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  12 in total

1.  mu-Opiate receptor agonists -- a new pharmacological approach to prevent motion sickness?

Authors:  Bärbel Otto; Rudolf L Riepl; Carsten Otto; Joachim Klose; Paul Enck; Sibylle Klosterhalfen
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

2.  Effects of the prodrug loperamide oxide, loperamide, and placebo on jejunal motor activity.

Authors:  G Stacher; H Steinringer; C Schneider; G V Vacariu-Granser; F Castiglione; G Gaupmann; U Weber; G Stacher-Janotta
Journal:  Dig Dis Sci       Date:  1992-02       Impact factor: 3.199

3.  Secretagogue-induced changes in membrane calcium permeability in chicken and chinchilla ileal mucosa. Selective inhibition by loperamide.

Authors:  E B Chang; D R Brown; N S Wang; M Field
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

4.  Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles.

Authors:  R N Alyautdin; V E Petrov; K Langer; A Berthold; D A Kharkevich; J Kreuter
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

5.  Opioid receptor characterisation of neuronally stimulated isolated human vas deferens.

Authors:  James Root; Ana Monica Lopes Correia Wakenhut; Holly Siggins; Sidath Katugampola; Carolyn Napier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-06-15       Impact factor: 3.000

6.  Opioids and sexual behavior in the male rabbit: the role of central and peripheral opioid receptors.

Authors:  A Agmo; R G Paredes; J L Contreras
Journal:  J Neural Transm Gen Sect       Date:  1994

7.  Smoked heroin self-administration in rhesus monkeys.

Authors:  A J Mattox; M E Carroll
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

8.  Effect of increasing oral doses of loperamide on gallbladder motility in man.

Authors:  W P Hopman; G Rosenbusch; J B Jansen; C B Lamers
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

9.  Loperamide mobilizes intracellular Ca2+ stores in insulin-secreting HIT-T15 cells.

Authors:  Li-Ping He; David Mears; Illani Atwater; Eduardo Rojas; Lars Cleemann
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

10.  Inhibitory effect of opiates on male rat sexual behavior may be mediated by opiate receptors outside the central nervous system.

Authors:  A Agmo; J Rojas; P Vázquez
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.